Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Charalampos Zoublios"'
Autor:
Eirini Papadopoulou, Nikolaos Tsoulos, Vasiliki Metaxa-Mariatou, Aikaterini Tsantikidi, Georgios Kapetsis, Chrysiida Florou-Chatzigiannidou, Sonia Maravelaki, Evgenia Bourkoula, Dimitrios Fotiou, Georgios Tsaousis, Nikolaos Touroutoglou, Dimitrios Trafalis, Ioannis Boukovinas, Ioannis Varthalitis, Zacharenia Saridaki, Charalampos Zoublios, Eleni Galani, George Papatsibas, Christos Papadimitriou, Tania Zlatintsi, Polixenia Iorga, Bülent Orhan, Sualp Tansan, Tahsin Özatlı, George Nasioulas
Publikováno v:
Cancer Research. 82:P5-13
Background: Comprehensive tumor analysis by Next Generation Sequencing (NGS) is imperative for targeted and immunotherapy related biomarkers’ analysis in metastatic breast cancer enabling personalization of cancer treatment in these patients. In pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a7cd5460c3f1348dc4d8b8ecdc50256
https://doi.org/10.1158/1538-7445.sabcs21-p5-13-01
https://doi.org/10.1158/1538-7445.sabcs21-p5-13-01
Autor:
Vasiliki Metaxa-Mariatou, Jubrail Dahabreh, Angela Apessos, Aggeliki Rapti, Vasileios Karavasilis, N Papageorgiou, Charalampos Zoublios, Mina Gaga, P. Zarogoulidis, Dimitrios Veldekis, George Nasioulas, Gerasimos Aravantinos, Stylianos Kakolyris, Konstantinos Zarogoulidis, Dimitrios Kasarakis, Napoleon Karagiannidis, Fotis Vlastos, Angeliki Tsirigoti, Eirini Papadopoulou, Konstantinos Agiannitopoulos, Nikolaos Tsoulos
Publikováno v:
Oncology Letters. 10:2176-2184
It has been reported that certain patients with non-small-cell lung cancer (NSCLC) that harbor activating somatic mutations within the tyrosine kinase domain of the epidermal growth factor receptor (EGFR) gene may be effectively treated using targete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b986f1f27c3c729a9a76c822e13137f
https://doi.org/10.3892/ol.2015.3600
https://doi.org/10.3892/ol.2015.3600
Autor:
Eirini, Papadopoulou, Nikolaos, Tsoulos, Angeliki, Tsirigoti, Angela, Apessos, Konstantinos, Agiannitopoulos, Vasiliki, Metaxa-Mariatou, Konstantinos, Zarogoulidis, Pavlos, Zarogoulidis, Dimitrios, Kasarakis, Stylianos, Kakolyris, Jubrail, Dahabreh, Fotis, Vlastos, Charalampos, Zoublios, Aggeliki, Rapti, Niki Georgatou, Papageorgiou, Dimitrios, Veldekis, Mina, Gaga, Gerasimos, Aravantinos, Vasileios, Karavasilis, Napoleon, Karagiannidis, George, Nasioulas
Publikováno v:
Oncology Letters
It has been reported that certain patients with non-small-cell lung cancer (NSCLC) that harbor activating somatic mutations within the tyrosine kinase domain of the epidermal growth factor receptor (EGFR) gene may be effectively treated using targete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6cae7cef4c762dc395df442895d1f4cc
https://pubmed.ncbi.nlm.nih.gov/26622815
https://pubmed.ncbi.nlm.nih.gov/26622815
Autor:
Paul Zarogoulidis, Vasiliki Metaxa-Mariatou, Konstantinos Agiannitopoulos, Vasilios Karavasilis, Gerasimos Aravantinos, Stylianos Kakolyris, George Nasioulas, Eirini Papadopoulou, Niki Georgatou-Papageorgiou, Jubrail Dahabreh, Charalampos Zoublios, K. Zarogoulidis, Angela Apessos, Fotis Vlastos, Aggeliki Rapti, Angeliki Tsirigoti, Dimitrios Kasarakis, Nikolaos Tsoulos
Publikováno v:
Journal of Clinical Oncology. 33:e22178-e22178
e22178 Background: NSCLC patients harboring activating somatic mutations within the tyrosine kinase (TK) domain of the epidermal growth factor receptor (EGFR) significantly benefit from EGFR target...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ddc182c88202d067d8a3c7bd84a55dfc
https://doi.org/10.1200/jco.2015.33.15_suppl.e22178
https://doi.org/10.1200/jco.2015.33.15_suppl.e22178